Product Information
IPRATROPIUM-ALBUTEROL 0.5-3(2.5) MG/3 ML is a generic product labeled by Cipla USA Inc., priced at $0.0787 per ML under NDC 69097084053. Its NADAC has been published 280 times since May 26, 2021.
FDA first approved this application on Oct 1, 2012. Its Orange Book therapeutic-equivalence code is AN.
Strength
2.5; .5 mg/3mL; mg/3mL
Manufacturer
Cipla USA Inc.NDC
69097084053
Classification
Generic
Dosage Form
SOLUTION
Route
RESPIRATORY (INHALATION)
Effective Date
9/23/2026
Active Ingredients
ALBUTEROL SULFATE; IPRATROPIUM BROMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA202496FDA Approved
10/1/2012
TE Code
AN
On Market Since
6/1/2020
Pharmacological Classes
Price Statistics
The NADAC for IPRATROPIUM-ALBUTEROL 0.5-3(2.5) MG/3 ML has been published 280 times since May 26, 2021, and over the history we have for it it has risen 30.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0787 per ML |
|---|---|
| All-time high | $0.1074 (Mar 13, 2024) |
| All-time low | $0.0569 (Dec 22, 2021) |
| 52-week high | $0.0926 |
| 52-week low | $0.0787 |
| Median price | $0.0856 |
| Average price | $0.0821 |
| Largest weekly change | +25.3% (Jul 19, 2023) |
| Weeks tracked | 280 |
| Tracking since | May 26, 2021 |
Generic Alternatives
The matcher finds 5 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Cipla USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Ipratropium Bromide and Albuterol Sulfate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Anticholinergic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of IPRATROPIUM-ALBUTEROL 0.5-3(2.5) MG/3 ML?
The current National Average Drug Acquisition Cost (NADAC) for IPRATROPIUM-ALBUTEROL 0.5-3(2.5) MG/3 ML, manufactured by Cipla USA Inc., is $0.0787 per ML (NDC 69097084053), effective Sep 30, 2026.
How has the price of IPRATROPIUM-ALBUTEROL 0.5-3(2.5) MG/3 ML changed over time?
Over the history we have for it, the NADAC for IPRATROPIUM-ALBUTEROL 0.5-3(2.5) MG/3 ML has risen 30.7%. It has been tracked across 280 weekly CMS publications since May 26, 2021.
What are the highest and lowest recorded NADAC prices for IPRATROPIUM-ALBUTEROL 0.5-3(2.5) MG/3 ML?
Since May 26, 2021, the NADAC for IPRATROPIUM-ALBUTEROL 0.5-3(2.5) MG/3 ML has ranged from a low of $0.0569 (Dec 22, 2021) to a high of $0.1074 (Mar 13, 2024), with a median of $0.0856 per ML.
Are there cheaper alternatives to IPRATROPIUM-ALBUTEROL 0.5-3(2.5) MG/3 ML?
5 manufacturers publish a NADAC-priced product with the same active ingredient and strength as IPRATROPIUM-ALBUTEROL 0.5-3(2.5) MG/3 ML in a comparable dosage form, but none are currently priced below it.
Who manufactures IPRATROPIUM-ALBUTEROL 0.5-3(2.5) MG/3 ML?
IPRATROPIUM-ALBUTEROL 0.5-3(2.5) MG/3 ML (NDC 69097084053) is labeled by Cipla USA Inc., and CMS classifies it as a generic product.